Literature DB >> 28274026

Symptomatic Remission in Schizophrenia and its Relationship with Functional Outcome Measures in Indian Population.

Selvaraj Madhivanan1, Komal Jayaraman2, Sharon Joe Daniel3, Jeyaprakash Ramasamy4.   

Abstract

INTRODUCTION: Schizophrenia is a chronic mental disorder with disabling symptoms and variable outcome. Outcome is a multidimensional construct that depends on description of clinical and social domains. Symptomatic remission is one such clinical domain which can determine the outcome of illness. AIM: The study aimed to assess functional outcome in symptomatic remitted schizophrenia patients compared to unremitted patients in Indian population.
MATERIALS AND METHODS: This cross-sectional observational study was conducted at the Institute of Mental Health, Chennai, India. Remitted (symptom free in preceding six months) and unremitted patients were assessed by Positive and Negative Symptom Scale (PANSS), Personal and Social Performance (PSP) scale, World Health Organization-Quality of Life BREF (WHOQOL-BREF) and Global Assessment of Functioning (GAF). There were 30 patients in each group. All statistical analysis was done using SPSS version 20.0 statistical software.
RESULTS: Patients in symptomatic remission were found to have better quality of life in personal, environmental and social domains (p<0.01). Their personal and social performance is significantly better in remission group. The overall functioning was assessed by GAF, was better in patients with symptomatic remission (p<0.001).
CONCLUSION: Symptomatic remission may be a good indicator of better clinical status, personal and social functioning and quality of life.

Entities:  

Keywords:  Mental health; Quality of life; Social functioning

Year:  2017        PMID: 28274026      PMCID: PMC5324471          DOI: 10.7860/JCDR/2017/22320.9242

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.

Authors:  Robin Emsley; Jonathan Rabinowitz; Rossella Medori
Journal:  Schizophr Res       Date:  2006-11-07       Impact factor: 4.939

2.  Prognostic variables at intake and long-term level of function in schizophrenia.

Authors:  Steven J Siegel; Farzin Irani; Colleen M Brensinger; Christian G Kohler; Warren B Bilker; J Daniel Ragland; Stephen J Kanes; Ruben C Gur; Raquel E Gur
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

3.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

4.  Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.

Authors:  Sofia Brissos; Vasco Videira Dias; Vicent Balanzá-Martinez; Ana Isabel Carita; Maria Luísa Figueira
Journal:  Schizophr Res       Date:  2011-04-22       Impact factor: 4.939

5.  Remission criteria for schizophrenia: evaluation in a large naturalistic cohort.

Authors:  Marc De Hert; Ruud van Winkel; Martien Wampers; John Kane; Jim van Os; Joseph Peuskens
Journal:  Schizophr Res       Date:  2007-03-02       Impact factor: 4.939

6.  Remission in schizophrenia: applying recent consensus criteria to refine the concept.

Authors:  Robert A Lasser; Henry Nasrallah; Lars Helldin; Joseph Peuskens; John Kane; John Docherty; Anselmo Toledo Tronco
Journal:  Schizophr Res       Date:  2007-08-31       Impact factor: 4.939

7.  Validation of remission criteria for schizophrenia.

Authors:  Jim van Os; Marjan Drukker; Joost à Campo; Jaap Meijer; M Bak; Philippe Delespaul
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

Review 8.  Long-term outcome of patients with schizophrenia: a review.

Authors:  Thomas H Jobe; Martin Harrow
Journal:  Can J Psychiatry       Date:  2005-12       Impact factor: 4.356

9.  Symptom remission in first episode patients.

Authors:  Jean Addington; Donald Addington
Journal:  Schizophr Res       Date:  2008-10-16       Impact factor: 4.939

10.  Outcome study of first-episode psychosis. I: Relapse rates after 1 year.

Authors:  C J Rabiner; J T Wegner; J M Kane
Journal:  Am J Psychiatry       Date:  1986-09       Impact factor: 18.112

View more
  1 in total

1.  The Association of Social Support and Symptomatic Remission among Community-Dwelling Schizophrenia Patients: A Cross-Sectional Study.

Authors:  Chi-Hsuan Fan; Shih-Chieh Hsu; Fei-Hsiu Hsiao; Chia-Ming Chang; Chia-Yih Liu; Yu-Ming Lai; Yu-Ting Chen
Journal:  Int J Environ Res Public Health       Date:  2021-04-09       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.